Consequently, HA entry inhibitors, including those to H7 HA, present unique opportunities for treating influenza, particularly for drug-resistant influenza strains, for which resistance is for therapeutics targeting the NA and/or the M2 channel and not HA. Here, XK is linked to influenza.